Ulfam en es it fr

Ulfam Brand names, Ulfam Analogs

Ulfam Brand Names Mixture

  • No information avaliable

Ulfam Chemical_Formula


Ulfam RX_link


Ulfam fda sheet

Ulfam FDA

Ulfam msds (material safety sheet)

Ulfam MSDS

Ulfam Synthesis Reference

H. Yasufumi et al.; U.S. Pat. 4,283,408 (1981)

Ulfam Molecular Weight

337.449 g/mol

Ulfam Melting Point

163-164 oC

Ulfam H2O Solubility

1.1 mg/mL

Ulfam State


Ulfam LogP


Ulfam Dosage Forms

Oral tablets; Rapid disintergrating tablets; Suspension; Injectable solution

Ulfam Indication

For the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD).

Ulfam Pharmacology

Famotidine, a competitive histamine H2-receptor antagonist, is used to treat gastrointestinal disorders such as gastric or duodenal ulcer, gastroesophageal reflux disease, and pathological hypersecretory conditions. Famotidine inhibits many of the isoenzymes of the hepatic CYP450 enzyme system. Other actions of Famotidine include an increase in gastric bacterial flora such as nitrate-reducing organisms.

Ulfam Absorption

The bioavailability of oral doses is 40-45%.

Ulfam side effects and Toxicity

Intravenous, mouse: LD50 = 244.4mg/kg; Oral, mouse: LD50 = 4686 mg/kg. Symptoms of overdose include emesis, restlessness, pallor of mucous membranes or redness of mouth and ears, hypotension, tachycardia and collapse.

Ulfam Patient Information

Famotidine is used to treat stomach and duodenal (upper small intestine) ulcers;
hypersecretory (increased acid secretion) conditions; heartburn and gastroesophageal
reflux disease (stomach contents bubbling into the esophagus causing pain). Notify your
physician if you are pregnant or nursing. Famotidine may be taken with or without food.
Shake the oral suspension vigorously for 5-10 seconds before taking. Unused oral
suspension should be discarded after 30 days. Notify your physician if you develop black,
tarry stools or coffee-ground vomit.

Ulfam Organisms Affected

Humans and other mammals